Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THDBH120 in overweight or obese subjects
NCT07036601Phase 2Recruiting
- Sponsor
- Tonghua Dongbao
- Start
- Jan 2025
- Primary completion
- Feb 2026
- Modality
- Recombinant Proteins and Enzymes, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of THDBH120 in obesity, Overweight, sponsored by Tonghua Dongbao. Started Jan 2025; status: recruiting.
02
Drugs
THDBH120
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT07036601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07036601.